Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

Domperidone for Relief of Gastrointestinal Disorders
Oral Domperidone for Relief of Gastrointestinal Disorders in Patients Who Failed Standard Therapy
Status: Archived
Carle Foundation Hospital
mi
from
Urbana, IL
Domperidone for Relief of Gastrointestinal Disorders
Oral Domperidone for Relief of Gastrointestinal Disorders in Patients Who Failed Standard Therapy
Status: Archived
Updated: 1/1/1970
Carle Foundation Hospital
mi
from
Urbana, IL
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Clinical Research Facility
mi
from
Birmingham, AL
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Birmingham, AL
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Clinical Research Facility
mi
from
Phoenix, AZ
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Phoenix, AZ
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Clinical Research Facility
mi
from
Little Rock, AR
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Little Rock, AR
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Clinical Research Facility
mi
from
San Diego, CA
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
San Diego, CA
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Clinical Research Facility
mi
from
Atlanta, GA
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Atlanta, GA
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Clinical Research Facility
mi
from
Evanston, IL
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Evanston, IL
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Clinical Research Facility
mi
from
Anderson, IN
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Anderson, IN
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Clinical Research Facility
mi
from
Baltimore, MD
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Baltimore, MD
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Clinical Research Facility
mi
from
Ayer, MA
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Ayer, MA
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Clinical Research Facility
mi
from
Detroit, MI
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Detroit, MI
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Clinical Research Facility
mi
from
St Louis, MO
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
St Louis, MO
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Clinical Research Facility
mi
from
Grand Island, NE
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Grand Island, NE
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Clinical Research Facility
mi
from
Teaneck, NJ
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Teaneck, NJ
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Clinical Research Facility
mi
from
Asheville, NC
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Asheville, NC
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Clinical Research Facility
mi
from
Akron, OH
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Akron, OH
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Clinical Research Facility
mi
from
Bend, OR
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Bend, OR
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Clinical Research Facility
mi
from
Allentown, PA
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Allentown, PA
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Clinical Research Facility
mi
from
Houston, TX
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Houston, TX
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Clinical Research Facility
mi
from
Salt Lake City, UT
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Salt Lake City, UT
BLI801 Laxative in Constipated Adults
A Pilot Efficacy Evaluation of BLI801 Laxative in Constipated Adults
Status: Archived
Advanced Clinical Research Institute
mi
from
Anaheim, CA
BLI801 Laxative in Constipated Adults
A Pilot Efficacy Evaluation of BLI801 Laxative in Constipated Adults
Status: Archived
Updated: 1/1/1970
Advanced Clinical Research Institute
mi
from
Anaheim, CA
BLI801 Laxative in Constipated Adults
A Pilot Efficacy Evaluation of BLI801 Laxative in Constipated Adults
Status: Archived
Jupiter Research
mi
from
Jupiter, FL
BLI801 Laxative in Constipated Adults
A Pilot Efficacy Evaluation of BLI801 Laxative in Constipated Adults
Status: Archived
Updated: 1/1/1970
Jupiter Research
mi
from
Jupiter, FL
BLI801 Laxative in Constipated Adults
A Pilot Efficacy Evaluation of BLI801 Laxative in Constipated Adults
Status: Archived
United Medical Research Institute
mi
from
New Smyrna Beach, FL
BLI801 Laxative in Constipated Adults
A Pilot Efficacy Evaluation of BLI801 Laxative in Constipated Adults
Status: Archived
Updated: 1/1/1970
United Medical Research Institute
mi
from
New Smyrna Beach, FL
Intestinal Microecology in Chronic Constipation
The Intestinal Microecology in Chronic Constipation
Status: Archived
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Intestinal Microecology in Chronic Constipation
The Intestinal Microecology in Chronic Constipation
Status: Archived
Updated: 1/1/1970
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Effects of ROSE-010 on GI Transit in Constipation Predominant Irritable Bowel Syndrome (C-IBS) Patients
Effect of ROSE-010 on Gastrointestinal Motor Functions in Female Patients With Constipation Predominant Irritable Bowel Syndrome (C-IBS)
Status: Archived
Mayo Clinic College of Medicine
mi
from
Rochester, MN
Effects of ROSE-010 on GI Transit in Constipation Predominant Irritable Bowel Syndrome (C-IBS) Patients
Effect of ROSE-010 on Gastrointestinal Motor Functions in Female Patients With Constipation Predominant Irritable Bowel Syndrome (C-IBS)
Status: Archived
Updated: 1/1/1970
Mayo Clinic College of Medicine
mi
from
Rochester, MN
The Effect of Lubiprostone on Patterns of Contractions in the Small Bowel in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS)
The Effect of Lubiprostone on Patterns of Contractions in the Small Bowel in Female Patients With C-IBS
Status: Archived
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
The Effect of Lubiprostone on Patterns of Contractions in the Small Bowel in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS)
The Effect of Lubiprostone on Patterns of Contractions in the Small Bowel in Female Patients With C-IBS
Status: Archived
Updated: 1/1/1970
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
A Study of Oral Methylnaltrexone (MNTX) for the Treatment of Opioid-Induced Constipation in Subjects With Chronic, Non-Malignant Pain
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Oral Methylnaltrexone (OM) for the Treatment of Opioid-Induced Constipation (OIC) in Subjects With Chronic, Non-Malignant Pain
Status: Archived
PRA International
mi
from
Raleigh, NC
A Study of Oral Methylnaltrexone (MNTX) for the Treatment of Opioid-Induced Constipation in Subjects With Chronic, Non-Malignant Pain
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Oral Methylnaltrexone (OM) for the Treatment of Opioid-Induced Constipation (OIC) in Subjects With Chronic, Non-Malignant Pain
Status: Archived
Updated: 1/1/1970
PRA International
mi
from
Raleigh, NC
Mechano-physiological Approach to Anorectal Function
Mechano-physiological Approach to Normal Anorectal Function and the Classification of Defecatory Disorders
Status: Enrolling
Updated:  12/31/1969
Hershey Medical Center
mi
from
Hershey, PA
Mechano-physiological Approach to Anorectal Function
Mechano-physiological Approach to Normal Anorectal Function and the Classification of Defecatory Disorders
Status: Enrolling
Updated: 12/31/1969
Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
A Colonic Tube to Improve Bowel Function in Spinal Cord Injury
Percutaneous Colostomy for Bowel Management in Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
Clement J. Zablocki VA Medical Center, Milwaukee, WI
mi
from
Milwaukee, WI
A Colonic Tube to Improve Bowel Function in Spinal Cord Injury
Percutaneous Colostomy for Bowel Management in Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Clement J. Zablocki VA Medical Center, Milwaukee, WI
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Randomized Controlled Trial of Treating Rectal Hypersensitivity - Comparing Escitalopram With Sensory Adaptation Training
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Randomized Controlled Trial of Treating Rectal Hypersensitivity - Comparing Escitalopram With Sensory Adaptation Training
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Investigation of Cortico-Rectal Pathways in Healthy Subjects and Constipated Patients
Investigation of Cortico-Rectal Pathways in Healthy Subjects and Constipated Patients
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Investigation of Cortico-Rectal Pathways in Healthy Subjects and Constipated Patients
Investigation of Cortico-Rectal Pathways in Healthy Subjects and Constipated Patients
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Sierra High Definition Ano-Rectal Manometry
Sierra High Definition Ano-Rectal Manometry
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Sierra High Definition Ano-Rectal Manometry
Sierra High Definition Ano-Rectal Manometry
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen
Treatment of Patients With Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen: a Randomized Double-blind Placebo-controlled Cross-over Trial
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen
Treatment of Patients With Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen: a Randomized Double-blind Placebo-controlled Cross-over Trial
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Effect of Lubiprostone on Methanogenesis and Bowel Function in Chronic Constipation.
Effect of Lubiprostone on Methanogenesis and Bowel Function in Chronic Constipation
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Effect of Lubiprostone on Methanogenesis and Bowel Function in Chronic Constipation.
Effect of Lubiprostone on Methanogenesis and Bowel Function in Chronic Constipation
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Effect of Lubiprostone on Methanogenesis and Bowel Function in Chronic Constipation.
Effect of Lubiprostone on Methanogenesis and Bowel Function in Chronic Constipation
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Effect of Lubiprostone on Methanogenesis and Bowel Function in Chronic Constipation.
Effect of Lubiprostone on Methanogenesis and Bowel Function in Chronic Constipation
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Coastal Clinical Research Inc
mi
from
Mobile, AL
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Coastal Clinical Research Inc
mi
from
Mobile, AL
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
East Valley Gastroenterology and Hepatology Associates, PC
mi
from
Chandler, AZ
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
East Valley Gastroenterology and Hepatology Associates, PC
mi
from
Chandler, AZ
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Genova Clinical Research
mi
from
Tucson, AZ
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Genova Clinical Research
mi
from
Tucson, AZ
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Adobe Clinical Research, LLC
mi
from
Tucson, AZ
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Adobe Clinical Research, LLC
mi
from
Tucson, AZ
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Desert Sun Clinical Research, LLC
mi
from
Tucson, AZ
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Desert Sun Clinical Research, LLC
mi
from
Tucson, AZ
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Preferred Research Partners, Inc.
mi
from
Little Rock, AR
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Preferred Research Partners, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
ACRI - Phase 1, LLC
mi
from
Anaheim, CA
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
ACRI - Phase 1, LLC
mi
from
Anaheim, CA
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
GW Research Inc,
mi
from
Chula Vista, CA
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
GW Research Inc,
mi
from
Chula Vista, CA
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Community Clinical Trials
mi
from
Orange, CA
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Community Clinical Trials
mi
from
Orange, CA
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Inland Gastroenterology Medical Associates
mi
from
Redlands, CA
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Inland Gastroenterology Medical Associates
mi
from
Redlands, CA
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Dormir Clinical Trials, Inc
mi
from
Redlands, CA
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Dormir Clinical Trials, Inc
mi
from
Redlands, CA
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Superior Research LLC
mi
from
Sacramento, CA
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Superior Research LLC
mi
from
Sacramento, CA
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Medical Center for clinical research
mi
from
San Diego, CA
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Medical Center for clinical research
mi
from
San Diego, CA
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Medical Associates Research Group
mi
from
San Diego, CA
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Medical Associates Research Group
mi
from
San Diego, CA
Click here to add this to my saved trials